Sandoz Anticipates Continued Sales Growth Driven by New Biosimilars

In a significant move poised to bolster its market position, Sandoz, a leading global supplier of generic pharmaceuticals and biosimilars, has announced its optimistic outlook for sales driven by the introduction of new biosimilar products. The company forecasts steady growth as it expands its portfolio in this fast-evolving segment of the pharmaceutical industry.

Continue reading